BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Clinical trial NCT06253195 · COMPLETED

Trial details

NCT number: NCT06253195
Sponsor: BeOne Medicines
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Metastatic Solid Tumor Hormone-receptor-positive Breast Cancer Breast Cancer Metastatic Breast Cancer Hormone Receptor Positive Malignant Neoplasm of Breast HER2-negative Breast Cancer

Start date: 2024-04-01
Primary completion: 2026-04-23
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.